ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Glutamate Receptor Ionotropic NMDA 2B Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-18V9921
Home | Market Reports | Science| Biological Sciences
Global Glutamate Receptor Ionotropic NMDA 2B Market Insights Forecast to 2028
BUY CHAPTERS

Global Glutamate Receptor Ionotropic NMDA 2B Market Research Report 2025

Code: QYRE-Auto-18V9921
Report
January 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
BioCrea GmbH
Bristol Myers Squibb Company
Cerecor Inc
Johnson & Johnson
Luc Therapeutics Inc
NeurOp Inc
Novartis
UCB

Glutamate Receptor Ionotropic NMDA 2B Market

The global market for Glutamate Receptor Ionotropic NMDA 2B was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Glutamate Receptor Ionotropic NMDA 2B is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Glutamate Receptor Ionotropic NMDA 2B is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Glutamate Receptor Ionotropic NMDA 2B include BioCrea GmbH, Bristol-Myers Squibb Company, Cerecor Inc., Johnson & Johnson, Luc Therapeutics, Inc., NeurOp, Inc, Novartis AG, UCB S.A., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Glutamate Receptor Ionotropic NMDA 2B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glutamate Receptor Ionotropic NMDA 2B.
The Glutamate Receptor Ionotropic NMDA 2B market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Glutamate Receptor Ionotropic NMDA 2B market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glutamate Receptor Ionotropic NMDA 2B manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Glutamate Receptor Ionotropic NMDA 2B Market Report

Report Metric Details
Report Name Glutamate Receptor Ionotropic NMDA 2B Market
Segment by Type
  • JNJ-0808
  • Neu-2000
  • NP-10679
  • NP-11948
  • Radiprodil
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company BioCrea GmbH, Bristol-Myers Squibb Company, Cerecor Inc., Johnson & Johnson, Luc Therapeutics, Inc., NeurOp, Inc, Novartis AG, UCB S.A.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Glutamate Receptor Ionotropic NMDA 2B manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Glutamate Receptor Ionotropic NMDA 2B in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Glutamate Receptor Ionotropic NMDA 2B Market report?

Ans: The main players in the Glutamate Receptor Ionotropic NMDA 2B Market are BioCrea GmbH, Bristol-Myers Squibb Company, Cerecor Inc., Johnson & Johnson, Luc Therapeutics, Inc., NeurOp, Inc, Novartis AG, UCB S.A.

What are the Application segmentation covered in the Glutamate Receptor Ionotropic NMDA 2B Market report?

Ans: The Applications covered in the Glutamate Receptor Ionotropic NMDA 2B Market report are Acute Ischemic Stroke, Autism, Brain Ischemia, Burns, Others

What are the Type segmentation covered in the Glutamate Receptor Ionotropic NMDA 2B Market report?

Ans: The Types covered in the Glutamate Receptor Ionotropic NMDA 2B Market report are JNJ-0808, Neu-2000, NP-10679, NP-11948, Radiprodil, Others

Recommended Reports

Glutamate & Amino Acids

Neurodegenerative Disorders

Receptor & Nerve Therapies

1 Glutamate Receptor Ionotropic NMDA 2B Market Overview
1.1 Product Definition
1.2 Glutamate Receptor Ionotropic NMDA 2B by Type
1.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Value Comparison by Type (2024 VS 2031)
1.2.2 JNJ-0808
1.2.3 Neu-2000
1.2.4 NP-10679
1.2.5 NP-11948
1.2.6 Radiprodil
1.2.7 Others
1.3 Glutamate Receptor Ionotropic NMDA 2B by Application
1.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Value by Application (2024 VS 2031)
1.3.2 Acute Ischemic Stroke
1.3.3 Autism
1.3.4 Brain Ischemia
1.3.5 Burns
1.3.6 Others
1.4 Global Glutamate Receptor Ionotropic NMDA 2B Market Size Estimates and Forecasts
1.4.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue 2020-2031
1.4.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales 2020-2031
1.4.3 Global Glutamate Receptor Ionotropic NMDA 2B Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Glutamate Receptor Ionotropic NMDA 2B Market Competition by Manufacturers
2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Manufacturers (2020-2025)
2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Glutamate Receptor Ionotropic NMDA 2B Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Glutamate Receptor Ionotropic NMDA 2B, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B, Product Type & Application
2.7 Global Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B, Date of Enter into This Industry
2.8 Global Glutamate Receptor Ionotropic NMDA 2B Market Competitive Situation and Trends
2.8.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Glutamate Receptor Ionotropic NMDA 2B Players Market Share by Revenue
2.8.3 Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Glutamate Receptor Ionotropic NMDA 2B Market Scenario by Region
3.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region: 2020-2031
3.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region: 2020-2025
3.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region: 2026-2031
3.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region: 2020-2031
3.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region: 2020-2025
3.3.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region: 2026-2031
3.4 North America Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country
3.4.1 North America Glutamate Receptor Ionotropic NMDA 2B Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2020-2031)
3.4.3 North America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country
3.5.1 Europe Glutamate Receptor Ionotropic NMDA 2B Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2020-2031)
3.5.3 Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Region
3.6.1 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2020-2031)
3.6.3 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country
3.7.1 Latin America Glutamate Receptor Ionotropic NMDA 2B Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2020-2031)
3.7.3 Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country
3.8.1 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2020-2031)
3.8.3 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2020-2031)
4.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2020-2025)
4.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2026-2031)
4.1.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2020-2031)
4.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2020-2031)
4.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2020-2025)
4.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2026-2031)
4.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2020-2031)
4.3 Global Glutamate Receptor Ionotropic NMDA 2B Price by Type (2020-2031)
5 Segment by Application
5.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2020-2031)
5.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2020-2025)
5.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2026-2031)
5.1.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2020-2031)
5.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2020-2031)
5.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2020-2025)
5.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2026-2031)
5.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2020-2031)
5.3 Global Glutamate Receptor Ionotropic NMDA 2B Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BioCrea GmbH
6.1.1 BioCrea GmbH Company Information
6.1.2 BioCrea GmbH Description and Business Overview
6.1.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.1.5 BioCrea GmbH Recent Developments/Updates
6.2 Bristol-Myers Squibb Company
6.2.1 Bristol-Myers Squibb Company Company Information
6.2.2 Bristol-Myers Squibb Company Description and Business Overview
6.2.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.2.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.3 Cerecor Inc.
6.3.1 Cerecor Inc. Company Information
6.3.2 Cerecor Inc. Description and Business Overview
6.3.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.3.5 Cerecor Inc. Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Company Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Luc Therapeutics, Inc.
6.5.1 Luc Therapeutics, Inc. Company Information
6.5.2 Luc Therapeutics, Inc. Description and Business Overview
6.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.5.5 Luc Therapeutics, Inc. Recent Developments/Updates
6.6 NeurOp, Inc
6.6.1 NeurOp, Inc Company Information
6.6.2 NeurOp, Inc Description and Business Overview
6.6.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2020-2025)
6.6.4 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.6.5 NeurOp, Inc Recent Developments/Updates
6.7 Novartis AG
6.7.1 Novartis AG Company Information
6.7.2 Novartis AG Description and Business Overview
6.7.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.7.5 Novartis AG Recent Developments/Updates
6.8 UCB S.A.
6.8.1 UCB S.A. Company Information
6.8.2 UCB S.A. Description and Business Overview
6.8.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2020-2025)
6.8.4 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.8.5 UCB S.A. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glutamate Receptor Ionotropic NMDA 2B Industry Chain Analysis
7.2 Glutamate Receptor Ionotropic NMDA 2B Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glutamate Receptor Ionotropic NMDA 2B Production Mode & Process Analysis
7.4 Glutamate Receptor Ionotropic NMDA 2B Sales and Marketing
7.4.1 Glutamate Receptor Ionotropic NMDA 2B Sales Channels
7.4.2 Glutamate Receptor Ionotropic NMDA 2B Distributors
7.5 Glutamate Receptor Ionotropic NMDA 2B Customer Analysis
8 Glutamate Receptor Ionotropic NMDA 2B Market Dynamics
8.1 Glutamate Receptor Ionotropic NMDA 2B Industry Trends
8.2 Glutamate Receptor Ionotropic NMDA 2B Market Drivers
8.3 Glutamate Receptor Ionotropic NMDA 2B Market Challenges
8.4 Glutamate Receptor Ionotropic NMDA 2B Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
BioCrea GmbH
Bristol Myers Squibb Company
Cerecor Inc
Johnson & Johnson
Luc Therapeutics Inc
NeurOp Inc
Novartis
UCB
List of Tables
 Table 1. Global Glutamate Receptor Ionotropic NMDA 2B Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Glutamate Receptor Ionotropic NMDA 2B Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Glutamate Receptor Ionotropic NMDA 2B Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Glutamate Receptor Ionotropic NMDA 2B Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Glutamate Receptor Ionotropic NMDA 2B Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Glutamate Receptor Ionotropic NMDA 2B, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B, Product Type & Application
 Table 12. Global Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Glutamate Receptor Ionotropic NMDA 2B by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glutamate Receptor Ionotropic NMDA 2B as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2020-2025)
 Table 19. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2026-2031)
 Table 21. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2020-2025)
 Table 23. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2026-2031)
 Table 25. North America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2020-2025)
 Table 53. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2026-2031)
 Table 54. Global Glutamate Receptor Ionotropic NMDA 2B Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Glutamate Receptor Ionotropic NMDA 2B Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2020-2025)
 Table 57. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2026-2031)
 Table 58. Global Glutamate Receptor Ionotropic NMDA 2B Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Glutamate Receptor Ionotropic NMDA 2B Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2020-2025)
 Table 63. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2026-2031)
 Table 64. Global Glutamate Receptor Ionotropic NMDA 2B Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Glutamate Receptor Ionotropic NMDA 2B Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2020-2025)
 Table 67. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2026-2031)
 Table 68. Global Glutamate Receptor Ionotropic NMDA 2B Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Glutamate Receptor Ionotropic NMDA 2B Price (USD/Pcs) by Application (2026-2031)
 Table 70. BioCrea GmbH Company Information
 Table 71. BioCrea GmbH Description and Business Overview
 Table 72. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product
 Table 74. BioCrea GmbH Recent Developments/Updates
 Table 75. Bristol-Myers Squibb Company Company Information
 Table 76. Bristol-Myers Squibb Company Description and Business Overview
 Table 77. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product
 Table 79. Bristol-Myers Squibb Company Recent Developments/Updates
 Table 80. Cerecor Inc. Company Information
 Table 81. Cerecor Inc. Description and Business Overview
 Table 82. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product
 Table 84. Cerecor Inc. Recent Developments/Updates
 Table 85. Johnson & Johnson Company Information
 Table 86. Johnson & Johnson Description and Business Overview
 Table 87. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product
 Table 89. Johnson & Johnson Recent Developments/Updates
 Table 90. Luc Therapeutics, Inc. Company Information
 Table 91. Luc Therapeutics, Inc. Description and Business Overview
 Table 92. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product
 Table 94. Luc Therapeutics, Inc. Recent Developments/Updates
 Table 95. NeurOp, Inc Company Information
 Table 96. NeurOp, Inc Description and Business Overview
 Table 97. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product
 Table 99. NeurOp, Inc Recent Developments/Updates
 Table 100. Novartis AG Company Information
 Table 101. Novartis AG Description and Business Overview
 Table 102. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product
 Table 104. Novartis AG Recent Developments/Updates
 Table 105. UCB S.A. Company Information
 Table 106. UCB S.A. Description and Business Overview
 Table 107. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product
 Table 109. UCB S.A. Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Glutamate Receptor Ionotropic NMDA 2B Distributors List
 Table 113. Glutamate Receptor Ionotropic NMDA 2B Customers List
 Table 114. Glutamate Receptor Ionotropic NMDA 2B Market Trends
 Table 115. Glutamate Receptor Ionotropic NMDA 2B Market Drivers
 Table 116. Glutamate Receptor Ionotropic NMDA 2B Market Challenges
 Table 117. Glutamate Receptor Ionotropic NMDA 2B Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Glutamate Receptor Ionotropic NMDA 2B
 Figure 2. Global Glutamate Receptor Ionotropic NMDA 2B Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Type: 2024 & 2031
 Figure 4. JNJ-0808 Product Picture
 Figure 5. Neu-2000 Product Picture
 Figure 6. NP-10679 Product Picture
 Figure 7. NP-11948 Product Picture
 Figure 8. Radiprodil Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Glutamate Receptor Ionotropic NMDA 2B Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Application: 2024 & 2031
 Figure 12. Acute Ischemic Stroke
 Figure 13. Autism
 Figure 14. Brain Ischemia
 Figure 15. Burns
 Figure 16. Others
 Figure 17. Global Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Glutamate Receptor Ionotropic NMDA 2B Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Glutamate Receptor Ionotropic NMDA 2B Sales (2020-2031) & (K Pcs)
 Figure 20. Global Glutamate Receptor Ionotropic NMDA 2B Average Price (USD/Pcs) & (2020-2031)
 Figure 21. Glutamate Receptor Ionotropic NMDA 2B Report Years Considered
 Figure 22. Glutamate Receptor Ionotropic NMDA 2B Sales Share by Manufacturers in 2024
 Figure 23. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest Glutamate Receptor Ionotropic NMDA 2B Players: Market Share by Revenue in Glutamate Receptor Ionotropic NMDA 2B in 2024
 Figure 25. Glutamate Receptor Ionotropic NMDA 2B Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2020-2031)
 Figure 28. North America Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country (2020-2031)
 Figure 29. U.S. Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2020-2031)
 Figure 32. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country (2020-2031)
 Figure 33. Germany Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2020-2031)
 Figure 40. China Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Taiwan Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Indonesia Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Thailand Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Malaysia Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Philippines Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2020-2031)
 Figure 51. Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country (2020-2031)
 Figure 52. Mexico Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Brazil Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Argentina Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country (2020-2031)
 Figure 57. Turkey Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. U.A.E Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Global Sales Market Share of Glutamate Receptor Ionotropic NMDA 2B by Type (2020-2031)
 Figure 61. Global Revenue Market Share of Glutamate Receptor Ionotropic NMDA 2B by Type (2020-2031)
 Figure 62. Global Glutamate Receptor Ionotropic NMDA 2B Price (USD/Pcs) by Type (2020-2031)
 Figure 63. Global Sales Market Share of Glutamate Receptor Ionotropic NMDA 2B by Application (2020-2031)
 Figure 64. Global Revenue Market Share of Glutamate Receptor Ionotropic NMDA 2B by Application (2020-2031)
 Figure 65. Global Glutamate Receptor Ionotropic NMDA 2B Price (USD/Pcs) by Application (2020-2031)
 Figure 66. Glutamate Receptor Ionotropic NMDA 2B Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global NMDA Receptor Antagonist Market Research Report 2025
Global Glutamate Antagonist Market Research Report 2025
Global L Arginine L Glutamate Market Research Report 2025
Global Metabotropic Glutamate Receptor 1 Market Research Report 2025
Global Calcium Diglutamate Market Research Report 2025
Sodium Glutamate for Food Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Glutamate Surfactants Market Research Report 2024
Global Glutamate Dehydrogenase Market Research Report 2024
Global 3 Amino 2 2 Dimethylpropionamide Market Research Report 2024
Global L Arginine L Pyroglutamate Market Research Report 2025
Global Memantine Market Research Report 2025
Global 5 Hydroxytryptamine Receptor 2B Market Research Report 2025
Global Monosodium L glutamate Market Research Report 2024
Global Neuromuscular Blocking Agent NMBA Market Insights Forecast to 2030
Global Calcium Diglutamate Powder Market Research Report 2024
Global MNI caged L glutamate Market Research Report 2025
Global Food Grade Calcium Diglutamate Market Research Report 2024
Global 2 Aminopropan Market Research Report 2025
Global Neuroplasticity Market Research Report 2024
Global Basic Amino Acid Market Research Report 2025

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions